BioLens is a free catalyst radar for biotech and pharma. It follows what happens to a drug on its way to patients: the trial results, the FDA filing, the expert panel, and the FDA decision (PDUFA) date. For every company you follow, you see what is coming next, which drug it is about, and how far along that drug is. Each event comes with its source, a link to the trial record or the company filing, and a clear label when a date is still an estimate. When a decision or a result comes in, the outcome is recorded next to it. BioLens also publishes independent research on individual companies: the science, the pipeline, the risks and what would prove the view wrong. Every note is written before the outcome is known and scored afterwards in an open track record. No account needed. Your list stays in your browser, and an optional free account syncs it across devices. Built by Thomas Bouman. Not financial advice.
| Website | https://bio-lens.net/ |
| Employees | 1 (1 on RocketReach) |
| Founded | 2026 |
| Industry | Financial Services |
Looking for a particular BioLens employee's phone or email?
Thomas Bouman is the Founder of BioLens.
1 people are employed at BioLens.